跳至主要内容
临床试验/NCT03211182
NCT03211182Unknown不适用

Evaluation on Prevention for Metabolic Syndrome and Diabetes Mellitus Through Lifestyle Modification Intervention in Prediabetic Subjects

Taipei Medical University8 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2012年3月7日最近更新:
适应症

试验速览

阶段
不适用
入组人数
300
试验地点
8
主要终点
blood sugar

研究概览

简要总结

The lifestyle intervention program focusing on healthy dietary habit and exercise effectively prevents progression to diabetes. Thus, the purpose of this study was to assess the effectiveness of lifestyle intervention program on pre-diabetics subjects in Taiwan.

详细描述

The study is a 2-parallel groups' randomized controlled trial. Participants with elevated fasting plasma glucose concentrations (FPG 100-125 mg/dl) or glycated hemoglobin (HbA1C 5.7-6.3%) are enrolled. All study subjects are randomized to receive a lifestyle intervention (intervention group) or regular prevention education (control group). The parameters are obtained from physical examination and biochemical assessments by well-trained case manager at baseline and each follow visit (3th months, 6th months and 12th months). All participants complete a structured questionnaire, including basic information, disease history, physical activity, food-frequency, stage of change, and social support situation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
40 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 40 years old or over
  • elevated fasting plasma glucose concentrations (FPG: 100-125 mg/dl) or glycated hemoglobin(HbA1C: 5.7-6.3%)

排除标准

  • having received a diagnosis of diabetes or receiving treatment for diabetes in 3 years
  • having a history of cardiovascular disease, stroke, liver disease, kidney disease, cardiopulmonary disease, malignancy or cancer and musculoskeletal impairment
  • receiving corticosteroids, androgens, estrogen containing compounds
  • who had dietary problem
  • pregnant women
  • who joined other health intervention study in one year.

结局指标

主要结局

blood sugar

时间窗: 3 month, 6 month and 12-month follow up

changes in fasting glucose and glycated hemoglobin

次要结局

  • body weight(3 month, 6 month and 12-month follow up)
  • BMI(3 month, 6 month and 12-month follow up)
  • Metabolic syndrome(3 month, 6 month and 12-month follow up)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验